BWXT revenue up 18% to $901.6M; agreed to sell medical unit for up

Filed August 3, 2026 · Period ending June 30, 2026 · Compared to 10-Q Aug 4, 2025 · ~1 min read

Key Changes

• high

  Agreed to sell its medical business to Nordic Capital for up to $800 million, reshaping the portfolio.

  MD&A: Sale of Medical Business verify on EDGAR →
• high

  Acquired Precision Components Group, adding heavy-manufacturing capacity for U.S. commercial nuclear work.

  MD&A: Acquisition of Precision Components Group verify on EDGAR →
• high

  Commercial Operations revenue jumped 71.7% to $302.5 million, driven by Kinectrics and organic growth.

  MD&A: Commercial Operations revenue growth verify on EDGAR →